Do analysts recommend WOK or LUCYW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score WORK Medical Technology Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, WOK or LUCYW?

Innovative Eyewear has lower revenue, but higher earnings than WORK Medical Technology Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio WORK Medical Technology Group $9.81M N/A -$1.07M N/A N/A Innovative Eyewear $3.41M N/A N/A N/A N/A

Is WOK or LUCYW more profitable?

Company Net Margins Return on Equity Return on Assets WORK Medical Technology Group N/A N/A N/A Innovative Eyewear N/A N/A N/A

Do analysts recommend NXGLW or WOK?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 WORK Medical Technology Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, NXGLW or WOK?

NEXGEL has higher revenue and earnings than WORK Medical Technology Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NEXGEL $12.07M N/A N/A N/A N/A WORK Medical Technology Group $9.81M N/A -$1.07M N/A N/A

Is NXGLW or WOK more profitable?

Company Net Margins Return on Equity Return on Assets NEXGEL N/A N/A N/A WORK Medical Technology Group N/A N/A N/A

Do analysts recommend WOK or MDLN?

Medline has a consensus price target of $47.42, suggesting a potential upside of 35.07%. Given Medline's stronger consensus rating and higher possible upside, analysts clearly believe Medline is more favorable than WORK Medical Technology Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score WORK Medical Technology Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Medline 1 Sell rating(s) 5 Hold rating(s) 21 Buy rating(s) 2 Strong Buy rating(s) 2.83

Which has better valuation and earnings, WOK or MDLN?

Medline has higher revenue and earnings than WORK Medical Technology Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio WORK Medical Technology Group $9.81M N/A -$1.07M N/A N/A Medline $28.43B 1.62 $1.16B $0.79 44.44

Is WOK or MDLN more profitable?

Company Net Margins Return on Equity Return on Assets WORK Medical Technology Group N/A N/A N/A Medline N/A N/A N/A

Do analysts recommend ALC or WOK?

Alcon presently has a consensus price target of $84.96, suggesting a potential upside of 18.30%. Given Alcon's stronger consensus rating and higher probable upside, analysts clearly believe Alcon is more favorable than WORK Medical Technology Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alcon 1 Sell rating(s) 6 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.61 WORK Medical Technology Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, ALC or WOK?

Alcon has higher revenue and earnings than WORK Medical Technology Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alcon $10.40B 3.42 $980M $1.31 54.82 WORK Medical Technology Group $9.81M N/A -$1.07M N/A N/A

Which has preferable earnings and valuation, WST or WOK?

West Pharmaceutical Services has higher revenue and earnings than WORK Medical Technology Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio West Pharmaceutical Services $3.07B 7.76 $493.70M $7.81 43.41 WORK Medical Technology Group $9.81M N/A -$1.07M N/A N/A

WORK Medical Technology Group (WOK) Competitors

$2.22 -0.02 (-0.89%)

As of 09/1/2026 04:00 PM Eastern

Compare

WOK vs. LUCYW, NXGLW, MDLN, ALC, and WST

Should you buy WORK Medical Technology Group stock or one of its competitors? WORK Medical Technology Group's main competitors and comparable companies include Innovative Eyewear (LUCYW), NEXGEL (NXGLW), Medline (MDLN), Alcon (ALC), and West Pharmaceutical Services (WST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does WORK Medical Technology Group compare to Innovative Eyewear?

WORK Medical Technology Group (NASDAQ:WOK) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WORK Medical Technology Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Innovative Eyewear has lower revenue, but higher earnings than WORK Medical Technology Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WORK Medical Technology Group	$9.81M	N/A	-$1.07M	N/A	N/A
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A

In the previous week, Innovative Eyewear's average media sentiment score of 1.92 beat WORK Medical Technology Group's score of 1.87 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company	Overall Sentiment
WORK Medical Technology Group	Very Positive
Innovative Eyewear	Very Positive

Company	Net Margins	Return on Equity	Return on Assets
WORK Medical Technology Group	N/A	N/A	N/A
Innovative Eyewear	N/A	N/A	N/A

Summary

WORK Medical Technology Group beats Innovative Eyewear on 2 of the 3 factors compared between the two stocks.

How does WORK Medical Technology Group compare to NEXGEL?

NEXGEL (NASDAQ:NXGLW) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

In the previous week, WORK Medical Technology Group's average media sentiment score of 1.87 beat NEXGEL's score of 0.44 indicating that WORK Medical Technology Group is being referred to more favorably in the news media.

Company	Overall Sentiment
NEXGEL	Neutral
WORK Medical Technology Group	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NEXGEL	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
WORK Medical Technology Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
NEXGEL	N/A	N/A	N/A
WORK Medical Technology Group	N/A	N/A	N/A

NEXGEL has higher revenue and earnings than WORK Medical Technology Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NEXGEL	$12.07M	N/A	N/A	N/A	N/A
WORK Medical Technology Group	$9.81M	N/A	-$1.07M	N/A	N/A

Summary

WORK Medical Technology Group beats NEXGEL on 2 of the 3 factors compared between the two stocks.

How does WORK Medical Technology Group compare to Medline?

WORK Medical Technology Group (NASDAQ:WOK) and Medline (NASDAQ:MDLN) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

In the previous week, Medline had 8 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 8 mentions for Medline and 0 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 1.87 beat Medline's score of 0.60 indicating that WORK Medical Technology Group is being referred to more favorably in the media.

Company	Overall Sentiment
WORK Medical Technology Group	Very Positive
Medline	Positive

Company	Net Margins	Return on Equity	Return on Assets
WORK Medical Technology Group	N/A	N/A	N/A
Medline	N/A	N/A	N/A

Medline has a consensus price target of $47.42, suggesting a potential upside of 35.07%. Given Medline's stronger consensus rating and higher possible upside, analysts clearly believe Medline is more favorable than WORK Medical Technology Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WORK Medical Technology Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83

Medline has higher revenue and earnings than WORK Medical Technology Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WORK Medical Technology Group	$9.81M	N/A	-$1.07M	N/A	N/A
Medline	$28.43B	1.62	$1.16B	$0.79	44.44

Summary

Medline beats WORK Medical Technology Group on 7 of the 8 factors compared between the two stocks.

How does WORK Medical Technology Group compare to Alcon?

Alcon (NYSE:ALC) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

In the previous week, Alcon had 4 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 4 mentions for Alcon and 0 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 1.87 beat Alcon's score of 0.20 indicating that WORK Medical Technology Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Alcon	Neutral
WORK Medical Technology Group	Very Positive

Alcon presently has a consensus price target of $84.96, suggesting a potential upside of 18.30%. Given Alcon's stronger consensus rating and higher probable upside, analysts clearly believe Alcon is more favorable than WORK Medical Technology Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.61
WORK Medical Technology Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Alcon has a net margin of 5.92% compared to WORK Medical Technology Group's net margin of 0.00%. Alcon's return on equity of 7.29% beat WORK Medical Technology Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	5.92%	7.29%	5.09%
WORK Medical Technology Group	N/A	N/A	N/A

Alcon has higher revenue and earnings than WORK Medical Technology Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.42	$980M	$1.31	54.82
WORK Medical Technology Group	$9.81M	N/A	-$1.07M	N/A	N/A

53.9% of Alcon shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Alcon has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, WORK Medical Technology Group has a beta of 1.74, indicating that its stock price is 74% more volatile than the broader market.

Summary

Alcon beats WORK Medical Technology Group on 11 of the 13 factors compared between the two stocks.

How does WORK Medical Technology Group compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

93.9% of West Pharmaceutical Services shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, West Pharmaceutical Services had 27 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 27 mentions for West Pharmaceutical Services and 0 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 1.87 beat West Pharmaceutical Services' score of 1.51 indicating that WORK Medical Technology Group is being referred to more favorably in the news media.

Company	Overall Sentiment
West Pharmaceutical Services	Very Positive
WORK Medical Technology Group	Very Positive

West Pharmaceutical Services has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, WORK Medical Technology Group has a beta of 1.74, suggesting that its stock price is 74% more volatile than the broader market.

West Pharmaceutical Services has a net margin of 16.98% compared to WORK Medical Technology Group's net margin of 0.00%. West Pharmaceutical Services' return on equity of 20.11% beat WORK Medical Technology Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.98%	20.11%	14.83%
WORK Medical Technology Group	N/A	N/A	N/A

West Pharmaceutical Services presently has a consensus target price of $368.08, indicating a potential upside of 8.56%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, equities research analysts clearly believe West Pharmaceutical Services is more favorable than WORK Medical Technology Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.87
WORK Medical Technology Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

West Pharmaceutical Services has higher revenue and earnings than WORK Medical Technology Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	7.76	$493.70M	$7.81	43.41
WORK Medical Technology Group	$9.81M	N/A	-$1.07M	N/A	N/A

Summary

West Pharmaceutical Services beats WORK Medical Technology Group on 12 of the 14 factors compared between the two stocks.

Get WORK Medical Technology Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WOK vs. The Competition

Export

Metric	WORK Medical Technology Group	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$5.81B	$7.15B	$12.83B
Dividend Yield	N/A	1.75%	2.53%	11.78%
P/E Ratio	N/A	25.70	271.62	24.97
Price / Sales	N/A	69.91	612.99	86.36
Price / Cash	N/A	33.16	77.20	52.85
Price / Book	N/A	6.04	12.92	6.03
Net Income	-$1.07M	$148.55M	$3.47B	$348.89M
7 Day Performance	-1.33%	-1.83%	-0.99%	-2.29%
1 Month Performance	12.69%	5.37%	7.14%	2.94%
1 Year Performance	-100.00%	5.31%	23.90%	14.08%

WORK Medical Technology Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WOK WORK Medical Technology Group	1.391 of 5 stars	$2.22 -0.9%	N/A	-100.0%	$0.00	$9.81M	N/A	226	Positive News
LUCYW Innovative Eyewear	N/A	$0.04 -0.2%	N/A	-62.6%	$0.00	$3.41M	N/A	9	Positive News
NXGLW NEXGEL	N/A	$0.02 +6.5%	N/A	-94.7%	$0.00	$12.07M	N/A	10	Gap Up
MDLN Medline	4.0216 of 5 stars	$34.58 -3.0%	$47.42 +37.1%	N/A	$46.86B	$28.43B	N/A	45,000
ALC Alcon	3.7489 of 5 stars	$72.71 -0.9%	$84.96 +16.9%	-10.0%	$36.29B	$10.40B	55.50	25,942

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:WOK) was last updated on 9/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

WORK Medical Technology Group (WOK) Competitors

WOK vs. LUCYW, NXGLW, MDLN, ALC, and WST

How does WORK Medical Technology Group compare to Innovative Eyewear?

Summary

How does WORK Medical Technology Group compare to NEXGEL?

Summary

How does WORK Medical Technology Group compare to Medline?

Summary

How does WORK Medical Technology Group compare to Alcon?

Summary

How does WORK Medical Technology Group compare to West Pharmaceutical Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WOK vs. The Competition

WORK Medical Technology Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

WORK Medical Technology Group (WOK) Competitors

WOK vs. LUCYW, NXGLW, MDLN, ALC, and WST

How does WORK Medical Technology Group compare to Innovative Eyewear?

Do analysts recommend WOK or LUCYW?

Which has preferable valuation and earnings, WOK or LUCYW?

Does the media refer more to WOK or LUCYW?

Is WOK or LUCYW more profitable?

Summary

How does WORK Medical Technology Group compare to NEXGEL?

Does the media favor NXGLW or WOK?

Do analysts recommend NXGLW or WOK?

Is NXGLW or WOK more profitable?

Which has higher valuation & earnings, NXGLW or WOK?

Summary

How does WORK Medical Technology Group compare to Medline?

Does the media prefer WOK or MDLN?

Is WOK or MDLN more profitable?

Do analysts recommend WOK or MDLN?

Which has better valuation and earnings, WOK or MDLN?

Summary

How does WORK Medical Technology Group compare to Alcon?

Does the media refer more to ALC or WOK?

Do analysts recommend ALC or WOK?

Is ALC or WOK more profitable?

Which has stronger earnings & valuation, ALC or WOK?

Do institutionals and insiders hold more shares of ALC or WOK?

Which has more volatility & risk, ALC or WOK?

Summary

How does WORK Medical Technology Group compare to West Pharmaceutical Services?

Do institutionals & insiders believe in WST or WOK?

Does the media favor WST or WOK?

Which has more risk and volatility, WST or WOK?

Is WST or WOK more profitable?

Do analysts recommend WST or WOK?

Which has preferable earnings and valuation, WST or WOK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WOK vs. The Competition

WORK Medical Technology Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools